FDA Panel Eyes New Heart Shunt Device Approval
Published Date: 11/3/2025
Notice
Summary
The FDA is hosting a virtual meeting on December 3, 2025, to discuss the V-Wave Ventura Interatrial Shunt System, a device that helps with heart blood flow. They’re inviting the public to share their thoughts by January 3, 2026, which could impact how this device is reviewed and possibly approved. This affects patients, doctors, and companies involved in heart health, with no direct costs announced yet.
Analyzed Economic Effects
5 provisions identified: 4 benefits, 0 costs, 1 mixed.
Advisory Panel Will Vote on Heart-Shunt PMA
On December 3, 2025, the FDA's Circulatory System Devices Panel will discuss, make recommendations, and vote on the premarket approval (PMA) application from V‑Wave, Inc. for the V‑Wave Ventura Interatrial Shunt System, a permanent implant indicated for New York Heart Association (NYHA) Class III heart failure patients who remain symptomatic despite guideline‑directed medical therapy.
Public Comments Accepted Through Jan 3, 2026
The FDA established docket FDA‑2025‑N‑4679 and will accept public comments through 11:59 p.m. Eastern Time on January 3, 2026. Comments submitted on or before November 14, 2025 will be provided to the Committee; later comments will be taken into consideration by FDA.
How to Request an Oral Presentation
Individuals wishing to make formal oral presentations must notify the contact person and submit a brief statement of the evidence or arguments, names/addresses of participants, and requested time by November 3, 2025; oral presentations are scheduled on December 3, 2025, between approximately 2 p.m. and 3 p.m. Eastern Time and may be time‑limited or selected by lottery if demand exceeds available slots.
Virtual Meeting with Accessibility Accommodations
The meeting will be held virtually on December 3, 2025 (9 a.m. to 6 p.m. ET) with presentations heard, captioned, recorded, and viewable online; persons requiring disability accommodations should contact CDR Daniel Bailey at Daniel.Bailey@fda.hhs.gov or 301-796-0048 at least 7 days before the meeting.
Procedure for Confidential Comment Submissions
If you want to submit confidential information, you must send a written/paper submission with two copies: one labeled "THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION" (for FDA review) and a second redacted copy for public viewing; confidential information will be handled under 21 CFR 10.20.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13047 — Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-13778 — Medical Device User Fee Amendments; Public Meeting; Request for Comments
The FDA is planning a public meeting on August 5, 2026, to talk about renewing fees that medical device makers pay to help speed up device reviews from 2028 to 2032. This affects companies making medical devices and could impact how much they pay and how fast their products get approved. The current fee program ends in September 2027, so the FDA wants your thoughts before finalizing new rules and fees.
2026-13716 — New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor
The FDA just updated the rules for new animal drugs, approving several new and generic medicines for pets and farm animals from early 2026. These changes help keep animal treatments safe and effective, and the updates take effect right away on July 7, 2026. If you’re a drug maker or animal caretaker, these approvals and sponsor changes could impact what medicines are available and when.
2026-13616 — Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
The FDA is officially pulling the plug on 34 drug approvals because the companies stopped selling these medicines. This change kicks in on August 5, 2026, and it mainly affects drug makers like Endo Operations and Pfizer. No money penalties here—just a clean break, but companies can ask to reapply if they want to bring the drugs back.
2026-13534 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Administrative Practices and Procedures; Formal Hearings
The FDA is asking for public feedback on how it collects information for formal hearings and administrative rules. This affects businesses and people who interact with the FDA, with no new costs but a chance to improve paperwork processes. Comments are due by August 5, 2026, so don’t miss your chance to weigh in!
2026-13519 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Premarket Approval of Medical Devices
The FDA is asking for public feedback on their paperwork rules for approving the most important and risky medical devices, like life-support machines. This review helps keep devices safe and effective before they hit the market. If you have thoughts, you’ve got until August 5, 2026, to share them—no cost changes, just a check-in on the info they collect.
Previous / Next Documents
Previous: 2025-19763 — Cost-of-Living Increase and Other Determinations for 2026
Starting December 2025, Social Security benefits will get a 2.8% boost, helping millions keep up with rising costs. This means higher monthly payments for retirees, disabled folks, and some veterans, plus updated limits on earnings and fees for 2026. If you get Social Security or Supplemental Security Income, expect a little more money in your pocket next year!
Next: 2025-19764 — Sunshine Act Meetings
The National Credit Union Administration is holding an open meeting on November 5, 2025, to discuss its budget for 2026-2027. This affects credit unions and anyone interested in how their money is managed. The meeting is a chance to see transparency in action with no cost changes announced yet.